Literature DB >> 17304109

Methylprednisolone reverses vasopressin hyporesponsiveness in ovine endotoxemia.

Christian Ertmer1, Hans-Georg Bone, Andrea Morelli, Hugo Van Aken, Michael Erren, Matthias Lange, Daniel L Traber, Martin Westphal.   

Abstract

Tachyphylaxis against catecholamines often complicates hemodynamic support in patients with septic shock. Recent experimental and clinical research suggests that the hemodynamic response to exogenous arginine vasopressin (AVP) infusion may also be blunted. The purpose of the present study was therefore to clarify whether the efficacy of a continuous AVP infusion (0.04 U x min(-1)) decreases over time in ovine endotoxemia. An additional objective was to determine whether the anticipated hyporesponsiveness can be counteracted by corticosteroids. Fourteen adult ewes (37 +/- 1 kg) were instrumented for chronic hemodynamic monitoring. All ewes received a continuous endotoxin infusion that contributed to a hypotensive-hyperdynamic circulation. After 16 h of endotoxemia, the sheep were randomized to receive either AVP (0.04 U x min(-1)) or the vehicle (normal saline; n = 7 each). After 6 h of AVP or placebo infusion, respectively, methylprednisolone (30 mg x kg(-1)) was injected. Arginine vasopressin infusion increased mean arterial pressure and systemic vascular resistance index at the expense of a reduced cardiac index (P < 0.05 each). Supraphysiologic AVP plasma levels in the treatment group (298 +/- 15 pg x mL(-1)) were associated with increased surrogate parameters of liver, mesenterial, and myocardial dysfunction. After 6 h of continuous AVP infusion, the vasopressor effect was significantly reduced. Interestingly, a bolus infusion of methylprednisolone (30 mg x kg(-1)) reestablished mean arterial pressure by increasing both cardiac index and systemic vascular resistance index. The present study demonstrates that in endotoxemia, (a) the vasopressor effect of AVP infusion may be reduced, (b) corticosteroids may potentially be useful to increase the efficacy of AVP infusion, and (c) even moderate AVP doses may potentially impair myocardial and hepatic function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17304109     DOI: 10.1097/01.shk.0000235140.97903.90

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  12 in total

1.  Effects of two different dosing regimens of terlipressin on organ functions in ovine endotoxemia.

Authors:  Matthias Lange; Christian Ertmer; Sebastian Rehberg; Andrea Morelli; Gabriele Köhler; Tim G Kampmeier; Hugo Van Aken; Martin Westphal
Journal:  Inflamm Res       Date:  2010-12-29       Impact factor: 4.575

2.  Proven infection-related sepsis induces a differential stress response early after ICU admission.

Authors:  Olivier Lesur; Jean-Francois Roussy; Frederic Chagnon; Nicole Gallo-Payet; Robert Dumaine; Philippe Sarret; Ahmed Chraibi; Lucie Chouinard; Bruno Hogue
Journal:  Crit Care       Date:  2010-07-09       Impact factor: 9.097

3.  Concomitant arginine-vasopressin and hydrocortisone therapy in severe septic shock: association with mortality.

Authors:  Christian Torgersen; Günter Luckner; Daniel C H Schröder; Christian A Schmittinger; Christopher Rex; Hanno Ulmer; Martin W Dünser
Journal:  Intensive Care Med       Date:  2011-07-21       Impact factor: 17.440

Review 4.  Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.

Authors:  Matthias Lange; Christian Ertmer; Martin Westphal
Journal:  Intensive Care Med       Date:  2007-12-08       Impact factor: 17.440

5.  Sepsis: a review for the neurohospitalist.

Authors:  Lioudmila V Karnatovskaia; Emir Festic
Journal:  Neurohospitalist       Date:  2012-10

6.  Corticosteroids for Septic Shock: Another Chapter in the Saga.

Authors:  Jason Yerke; Kyle Strnad; Seth R Bauer
Journal:  Hosp Pharm       Date:  2019-02-09

Review 7.  Bench-to-bedside review: Vasopressin in the management of septic shock.

Authors:  James A Russell
Journal:  Crit Care       Date:  2011-08-11       Impact factor: 9.097

8.  Dobutamine reverses the vasopressin-associated impairment in cardiac index and systemic oxygen supply in ovine endotoxemia.

Authors:  Christian Ertmer; Andrea Morelli; Hans-Georg Bone; Henning Dirk Stubbe; Ralf Schepers; Hugo Van Aken; Matthias Lange; Katrin Bröking; Martin Lücke; Daniel L Traber; Martin Westphal
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

9.  Comparison of Gene Expression by Sheep and Human Blood Stimulated with the TLR4 Agonists Lipopolysaccharide and Monophosphoryl Lipid A.

Authors:  Perenlei Enkhbaatar; Christina Nelson; John R Salsbury; Joseph R Carmical; Karen E O Torres; David Herndon; Donald S Prough; Liming Luan; Edward R Sherwood
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

10.  Vasopressin in Septic Shock; Assessment of Sepsis Biomarkers: A Randomized, Controlled Trial.

Authors:  Elchin Barzegar; Masoumeh Nouri; Sarah Mousavi; Arezoo Ahmadi; Mojtaba Mojtahedzadeh
Journal:  Indian J Crit Care Med       Date:  2017-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.